ConvaTec Group PLC (CTEC) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally.

Total Assets Chart for ConvaTec Group PLC

ConvaTec Group PLC (CTEC) total assets for FY2025 were GBP 3.8B, a 7.6% change from FY2024. ConvaTec Group PLC's total assets grew from GBP 4.7B in 2009 to GBP 3.8B in 2025 (-20.0% over 16 years). Total assets compound annual growth rate: 5-year CAGR of 0.1%, 10-year CAGR of -0.0%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (British Pounds)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
£4.48B
Implied Share Price
£2.30
Enterprise Value
£5.79B
Revenue (TTM)
£2.49B
EBITDA
£582.00M
Profit Margin
4.98%
Trailing P/E
45.92
Forward P/E
15.75
Price/Book (MRQ)
4.30
Price/Sales (TTM)
1.80
EV/EBITDA
17.25
EV/Revenue
3.13
Dividend Yield
3.24%
Book Value
£0.54
Free Cash Flow (FY2025)
£342.03M
Free Cash Flow Yield
7.64%

Snapshot as of 15th August 2026 — not point-in-time controlled, may lag the live market by a few days.